From January 1, 2024 to March 31, 2024, the company has repurchased 1,040,000 shares, representing 1.28% for $35.65 million. With this, the company has completed the repurchase of 1,507,585 shares, representing 1.86% for $50.66 million under the buyback announced on October 26, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.63 USD | +0.18% |
|
+2.10% | -3.60% |
04/06 | AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders. | CI |
03/06 | After trial, investors weigh Trump 2.0 factor as election looms | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.60% | 261.45Cr | |
+27.76% | 9.53TCr | |
-4.98% | 9.45TCr | |
+13.53% | 2.7TCr | |
-9.40% | 1.72TCr | |
-2.41% | 1.43TCr | |
+0.65% | 1.36TCr | |
-23.80% | 1.2TCr | |
+26.19% | 1.05TCr | |
+19.83% | 919.28Cr |
- Stock Market
- Equities
- FHI Stock
- News Federated Hermes, Inc.
- Tranche Update on Federated Hermes, Inc.'s Equity Buyback Plan announced on October 26, 2023.